Biallelic loss of SMARCB1 underlies the key genetic abnormality in atypical rhabdoid/teratoid tumour (AT/RT) and malignant rhabdoid tumour, both aggressive cancers of childhood [5], as well as epithelioid sarcoma [6]. The gene discussed is SMARCB1; the disease is rhabdoid tumor.